PDD's strategic investments create near-term volatility despite long-term potential. Hold current positions while new ...

Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...

Market experts expect a premium listing for the stock, supported by strong investor interest and positive sentiment around ...

The listing premium is lower than the 19.91% GMP with which unlisted shares of the company were trading in the grey market, ...

Chandan Taparia has recommended three stocks to buy today – Housing & Urban Development Corporation (HUDCO), ITC, and Bharat ...

What to expect from NVIDIA's fiscal first-quarter earnings, and how will the results impact investors' sentiment?

The biggest weekly decline for stocks since early April is again testing the risk appetite of everyday investors.

Are Bendigo and Adelaide Bank Ltd (ASX: BEN) shares a buy after Friday’s earnings results? Here’s what Macquarie recommends.

The lithium market has been volatile in 2025. Here's what Macquarie is projecting for lithium companies like Liontown ...

Sun Pharmaceutical Industries reported a consolidated net profit of ₹2,154 crore in the fourth quarter of FY25, registering a ...

Financial services software company Iress presents a good buy due to its strong recurring revenue, strategic focus on core Australian markets, expected 3.7% annual earnings growth and a forecast 19.4% ...

ITC shares rose over 1% after Q4 FY25 results showed a marginal profit rise and strong revenue growth. Nuvama weighs in on key business segments and future outlook.